Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress™ 2020

    NEXT STORY
    MediPharm Labs Launches New Sublingual Sprays for Sale via Medical Cannabis by Shoppers™ Under Agreement With Avicanna
    PREV STORY
    Electrosurgery Market to reach US $6.7 billion by 2025 – Global Insights on Trends, Size, Price Trend Analysis, Value Chain analysis, Key Drivers, and Future Prospect: Adroit Market Research
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Physician-led Online Healthcare Technology Company Applies for Novel Clinical Trial for COVID-19 Using Medical Cannabis

    author_avatar
    NASDAQ Market News

    Cancer Genetics, Inc. and Sayre Therapeutics Announce Distribution Agreement to Commercialize CGI’s Proprietary FDA-cleared Tissue of Origin (TOO®) Test Throughout India and South Asia

    TOO® is the ONLY FDA-cleared test of its type, used to aid in identifying ...

    author_avatar
    NASDAQ Market News

    Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 CD47 Programs

    author_avatar
    NASDAQ Market News